Cargando…

Improving Medication‐Related Outcomes in Chronic Liver Disease

Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayward, Kelly L., Weersink, Rianne A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603526/
https://www.ncbi.nlm.nih.gov/pubmed/33163829
http://dx.doi.org/10.1002/hep4.1612
_version_ 1783603941945114624
author Hayward, Kelly L.
Weersink, Rianne A.
author_facet Hayward, Kelly L.
Weersink, Rianne A.
author_sort Hayward, Kelly L.
collection PubMed
description Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication‐related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined. This narrative literature review discusses key barriers and opportunities to modify risk factors and improve medication‐related outcomes for people with CLD.
format Online
Article
Text
id pubmed-7603526
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76035262020-11-05 Improving Medication‐Related Outcomes in Chronic Liver Disease Hayward, Kelly L. Weersink, Rianne A. Hepatol Commun Review Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medication‐related problems (MRPs) have been associated with adverse patient outcomes, including hospitalization and mortality. Factors that can contribute to MRPs in people with CLD are variable and often entwined. This narrative literature review discusses key barriers and opportunities to modify risk factors and improve medication‐related outcomes for people with CLD. John Wiley and Sons Inc. 2020-10-10 /pmc/articles/PMC7603526/ /pubmed/33163829 http://dx.doi.org/10.1002/hep4.1612 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review
Hayward, Kelly L.
Weersink, Rianne A.
Improving Medication‐Related Outcomes in Chronic Liver Disease
title Improving Medication‐Related Outcomes in Chronic Liver Disease
title_full Improving Medication‐Related Outcomes in Chronic Liver Disease
title_fullStr Improving Medication‐Related Outcomes in Chronic Liver Disease
title_full_unstemmed Improving Medication‐Related Outcomes in Chronic Liver Disease
title_short Improving Medication‐Related Outcomes in Chronic Liver Disease
title_sort improving medication‐related outcomes in chronic liver disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603526/
https://www.ncbi.nlm.nih.gov/pubmed/33163829
http://dx.doi.org/10.1002/hep4.1612
work_keys_str_mv AT haywardkellyl improvingmedicationrelatedoutcomesinchronicliverdisease
AT weersinkriannea improvingmedicationrelatedoutcomesinchronicliverdisease